Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Clinical outcomes according to ethnicity in patients with metastatic renal cell carcinoma (mRCC) treated with VEGF-targeted therapy (TT). Bosse, D., Xie, W., Wells, C., Lalani, A. A., Donskov, F., Bent, A., Sim, H., Beuselinck, B., Bamias, A., Porta, C., Vaishampayan, U. N., Pal, S. K., Agarwal, N., Srinivas, S., Rini, B. I., Alva, A., Wood, L., Kapoor, A., Choueiri, T. K., Heng, D. AMER SOC CLINICAL ONCOLOGY. 2017
View details for DOI 10.1200/JCO.2017.35.15_suppl.e16065
View details for Web of Science ID 000411931702156